Update: Who Has Signed Abbvie Licensing Agreements for Adalimumab Biosimilars?

Company/Partner Drug Name Launch Date
Amgen Amjevita* January 2023
Samsung Bioepis/Merck SB5 June 2023
Mylan/Fujifilm Kyowa Kirin Biologics Hulio August 2023
Fresenius Kabi MSB11022 September 2023
Sandoz Hyrimoz* September 2023
Pfizer PF-06410293 November 2023
Momenta M923 December 2023
Coherus CHS-1720 December 2023
*Received FDA Approval.

Leave a Reply